New evidence published today in the Cochrane Library shows that hormone replacement therapy (HRT) does not protect post-menopausal women against cardiovascular disease, and may even cause an increased risk of stroke.
Newly published SWAN research shows that menopausal symptoms may continue for up to 14 years.
As hormone levels change during the transition to menopause, the quality of a woman’s cholesterol carriers degrades, leaving her at greater risk for heart disease.
Our Principal Investigator, Sioban Harlow, will lead the sessions that will discuss what we have learned together with an update on the future direction of the study.
Despite evidence suggesting that women whose uterus has been removed may be more likely to experience heart troubles, a new study finds that the usual signs of heart disease risk are not more severe in middle-aged women after hysterectomy.